Leading up to my diagnosis, cancer wasn’t even on my radar. I found a lump, yes, but everyone around me — doctors, nurses, friends — reassured me it was probably nothing.

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to study results published in Journal of Cancer Survivorship.

Human health is complex and diagnostic tools and their limitations, so missing a diagnosis is sometimes unavoidable.

Are patients being prescribed more medications not for their health, but to generate profit?

Congressman Greg Murphy, M.D., alongside Congressmen Adam Gray (D-CA) and Neal Dunn (R-FL), introduced the Protecting Patient Access to Cancer and Complex Therapies Act, legislation to revert physician reimbursement for administering drugs under Medicare Part B to Average Sales Price (ASP) plus 6 percent, create an additional rebate paid by manufacturers, and hold patients harmless by basing coinsurance rates off the Maximum Fair Price (MFP).

Rural hospitals across the U.S. say they’re being forced to consider tough choices — like cutting services for children or cancer patients — after President Donald Trump signed into law a sprawling domestic policy bill that includes sweeping cuts to not only Medicaid but the Affordable Care Act, as well.

The Community Oncology Alliance (COA) strongly supports the reintroduction of the Protecting Patient Access to Cancer and Complex Therapies Act in the United States House of Representatives.

Kelli Reardon undergoes an MRI twice a year to screen for breast cancer, a measure she said she must take to protect her health.

Chemotherapy doesn’t just attack cancer cells; it often takes the nervous system along for the ride.

Administrative delays and insurance red tape experienced by patients with advanced cancer can lead to feelings of fear and mistrust in a healthcare system which they believed would protect them in their most vulnerable state, Dr. Alexandra Zaleta said in an interview with CURE.